about
A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptidesCollagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1Antiplatelet medication after liver transplantation: does it affect outcome?Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosisHypothermic oxygenated machine perfusion prevents arteriolonecrosis of the peribiliary plexus in pig livers donated after circulatory deathCriteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusionPlatelet function in stored heparinised autologous blood is not superior to in patient platelet function during routine cardiopulmonary bypassSynergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisIs there a rationale for treatment of chronic liver disease with antithrombotic therapy?Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.Activation and regulation of hemostasis in acute liver failure and acute pancreatitis.Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure.Transient von Willebrand factor-mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice.Hemostatic issues in pregnancy-induced liver disease.Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory deathProthrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in MiceProcoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease.Fibrinolysis and the risk of venous and arterial thrombosis.Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography.Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions.Tissue factor-independent effects of recombinant factor VIIa on hemostasis.Platelets in liver transplantation: friend or foe?Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in menThe two tales of coagulation in liver transplantation.The platelet and platelet function testing in liver disease.The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.The interaction of recombinant factor VIIa with platelet glycoprotein Ib.The International Normalized Ratio (INR) in the MELD score: problems and solutions.Protection of bile ducts in liver transplantation: looking beyond ischemia.Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient.Hemostasis in liver disease: implications of new concepts for perioperative management.Management of coagulation abnormalities in liver disease.The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa.
P50
Q24299888-1806859C-5D50-473A-9D63-6CAA50584EBCQ24338828-8C1F4B36-ABF1-41D2-8234-49418FC59002Q28222511-9FEAF07C-9AF0-4069-BE92-E0DAFEDF58B0Q28539503-42A7B80B-6E04-40FF-9F33-4FD5FCEC8D96Q28539817-541E1704-88B9-4558-909B-6C9C1C63110BQ28544697-59279221-F2CB-470B-A2DC-C50F8BF09F37Q28731224-FDCE7643-73BF-4045-813F-C15244EFF3B9Q28754730-637A7935-A623-4732-BBE5-2219EFCDF31FQ30301176-9BE4F566-922F-4F63-9451-5B0919C7C75CQ30441462-289D531C-0F59-4337-9200-E2111F4D0DC9Q30456742-C872D769-CEA6-4E59-A1D9-1D6FE67B8D89Q33365901-06760FA6-EFBA-42DD-87E4-2F0FAD77F6C7Q33378519-819D64E1-6718-413B-A943-D5FD5AB46C3AQ33390575-DE508F0B-7F7A-4A92-BFE5-B97081E01C91Q33406775-A96F18B6-878F-48A6-868A-BB35D20544DFQ33426589-B57599A9-B992-43AD-945E-DF2DA4E7C6DFQ33439157-CE8B9CCA-BA33-4F15-AB49-8792EF7B9323Q33439860-19F059CF-4F9D-4481-B431-7A3FB8DB0A2AQ33835595-307A6122-A8DC-4827-AB91-AF77DFE1D2CAQ34788255-71DC88ED-D1DF-4124-8C94-24852EF12A64Q35850661-26093E7C-3990-4900-96C8-C02F1CD9D472Q35911484-44629312-D738-4EA0-AAAE-359B6A8E397BQ36076903-69F397D3-72FF-413E-B83C-EF9AE0FC2716Q36783473-197E68F0-A494-40A8-A598-280EF165FA5AQ36893485-7CDA31AE-1B3E-44F2-810F-DA752BFB0B1AQ37093069-E46D5819-419E-40C6-ADAA-1876275B00F3Q37117957-97855AB0-05C6-416F-9209-69240BCE0532Q37187981-89171792-FCE0-480F-8297-3C71BC53CA3EQ37200718-FA399CD8-74AE-4BF3-8BEC-3BCB470005BFQ37207774-D05BBB42-0EDC-453E-99F9-037F6E05C425Q37236925-3FA572A6-2C31-4C63-ACE7-B1D3B21FA18EQ37371061-E4969FEE-A35C-4B18-A790-2C33D10869BDQ37593974-70C4BCE1-F155-4D46-9680-FF7EDFDB6E1CQ37691739-91BB66C1-FC84-488E-B7BC-4130709CE475Q37719751-2D086A62-BD57-4C84-B15A-08F1D197B331Q37882999-20000B94-E635-41AC-8889-3FAD9370A040Q38089361-36C1F175-5B37-49D7-BDE6-B2EA1E8B1842Q38203701-3A5C75A0-7AEF-4387-A0AF-805A0C41E5C5Q38223728-AC4B13EC-F6BC-43FD-A1DF-A8235D408128Q38305649-8ABB4014-861B-4D7D-8D98-C74725C40AF0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ton Lisman
@ast
Ton Lisman
@en
Ton Lisman
@es
Ton Lisman
@nl
Ton Lisman
@sl
type
label
Ton Lisman
@ast
Ton Lisman
@en
Ton Lisman
@es
Ton Lisman
@nl
Ton Lisman
@sl
prefLabel
Ton Lisman
@ast
Ton Lisman
@en
Ton Lisman
@es
Ton Lisman
@nl
Ton Lisman
@sl
P106
P1153
6603763619
P21
P31
P496
0000-0002-3503-7140
P569
2000-01-01T00:00:00Z